Mon, 5th Mar 2018 07:00
MD Medical Group opens new hospital in
5 March 2018,
Mother&Child Samara has 15,000 sq m of space, with six storeys. The hospital has 164 beds and annual capacity of up to 2,500 deliveries, up to 1,200 IVF cycles, 220,000 out-patient visits and 8,000 surgical operations. Total investment in the project amounted to
The hospital in
Mother&Child Samara has eight high-tech operating theatres including one integrated facility that allows remote consultations with doctors at other MDMG facilities, meaning that surgical operations can be carried out using telemedicine technology.
The hospital's diagnostics centre will offer an extensive range of services including CT, MRI, mammography, X-ray and ultrasound diagnostics, endovascular surgery, an endoscopy department and a diagnostics laboratory capable of carrying out more than 1,000 types of tests including genetic testing (gene mapping, Karyotype testing, and diagnosis of hereditary diseases).
MD Medical Group has assembled an excellent team of doctors for the
Mark Kurtser, CEO of MD Medical Group, said:
"The opening of Mother&Child Samara demonstrates our ability to execute strategically important projects on time and on budget. The new hospital represents a substantial strengthening of the Company's position in an important and growing market in the south-east of the European part of Russia. As well as Samara itself, the hospital will offer medical services to surrounding areas in the Volga region, thanks to the hospital's easily accessible location just outside Samara with advanced transportation infrastructure that has been put in place for the World Cup games in the city.
"MD Medical Group has a solid track record in the Samara Region, with several clinics successfully operating in the city already for a number of years and the IDK Medical Company that we acquired in 2013 enjoying a strong reputation as one of the leading private healthcare providers. The creation of a regional base and establishment of local brand awareness and subsequent construction of a major hi-tech medical centre with a strong team of doctors is in line with our long-term development strategy which includes creating a chain of multi-disciplinary hospitals in Russia's regions.
"We are proud that the new hospital in Samara will make high-quality medical care accessible to hundreds of thousands of people in the Volga region."
Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) and MD Medical Group Board member added:
"The team at MD Medical Group not only exhibits the highest levels of professionalism in providing medical care but they are also successfully expanding the network. Investors welcome the development and opening of ultra-modern hospitals which have a positive impact not only on the communities and economies of the regions where they are located, but also on the financial performance of the company. We are pleased that RDIF and its co-investors are contributing to projects which are both profitable and worthwhile.
"The opening of the hospital in
For further information please contact:
MD Medical Group Investments Plc
Tel: +7 495 331 4120 firstname.lastname@example.org
EMTom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 35 modern healthcare facilities, including 5 hospitals and 30 outpatient clinics in
The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.